Theranos Gets Additional Week to Respond to U.S. InspectionBy
Blood-test startup has hired new director for California lab
Regulators had ordered changes at lab, threatened sanctions
Blood-testing startup Theranos Inc. said it has been given a one-week extension by U.S. regulators to say how it will fix flaws at a California laboratory.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.